ELEVANCE HEALTH, INC. Cost of Revenue
ELEVANCE HEALTH, INC. (ELV) reported Cost of Revenue of $5.49 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-15.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-15
- ELEVANCE HEALTH, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $5.49B, a 3.76% increase year-over-year.
- ELEVANCE HEALTH, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $5.46B, a 9.63% increase year-over-year.
- ELEVANCE HEALTH, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $5.52B, a 8.15% decline year-over-year.
- ELEVANCE HEALTH, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $5.38B, a 5.64% increase year-over-year.
- ELEVANCE HEALTH, INC. cost of goods and services sold for fiscal 2025 was $21.18B, a 7.23% increase from fiscal 2024.
- ELEVANCE HEALTH, INC. cost of goods and services sold for fiscal 2024 was $19.75B, a 14.21% increase from fiscal 2023.
- ELEVANCE HEALTH, INC. cost of goods and services sold for fiscal 2023 was $17.29B, a 32.67% increase from fiscal 2022.
- ELEVANCE HEALTH, INC. cost of goods and services sold for fiscal 2022 was $13.04B, a 19.64% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.49B 10-Q · filed 2026-07-15 | $10.96B 10-Q · filed 2026-07-15 | $16.48B derived: sum of 3 quarters · filed 2026-07-15 | $21.86B derived: sum of 4 quarters · filed 2026-07-15 |
| 2026-03-31 | $5.46B 10-Q · filed 2026-04-22 | $10.98B derived: sum of 2 quarters · filed 2026-04-22 | $16.36B derived: sum of 3 quarters · filed 2026-04-22 | $21.66B derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-12-31 | $5.52B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $10.90B derived: sum of 2 quarters · filed 2026-02-06 | $16.20B derived: sum of 3 quarters · filed 2026-07-15 | $21.18B 10-K · filed 2026-02-06 |
| 2025-09-30 | $5.38B 10-Q · filed 2025-10-21 | $10.67B derived: sum of 2 quarters · filed 2026-07-15 | $15.66B 10-Q · filed 2025-10-21 | $21.67B derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-06-30 | $5.29B 10-Q · filed 2026-07-15 | $10.28B 10-Q · filed 2026-07-15 | $16.29B derived: sum of 3 quarters · filed 2026-07-15 | $21.38B derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-03-31 | $4.98B 10-Q · filed 2026-04-22 | $10.99B derived: sum of 2 quarters · filed 2026-04-22 | $16.09B derived: sum of 3 quarters · filed 2026-04-22 | $20.91B derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-12-31 | $6.01B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $11.11B derived: sum of 2 quarters · filed 2026-02-06 | $15.93B derived: sum of 3 quarters · filed 2026-02-06 | $19.75B 10-K · filed 2026-02-06 |
| 2024-09-30 | $5.09B 10-Q · filed 2025-10-21 | $9.91B derived: sum of 2 quarters · filed 2025-10-21 | $13.74B 10-Q · filed 2025-10-21 | $18.57B derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-06-30 | $4.82B 10-Q · filed 2025-07-17 | $8.64B 10-Q · filed 2025-07-17 | $13.48B derived: sum of 3 quarters · filed 2026-02-06 | $18.13B derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-03-31 | $3.83B 10-Q · filed 2025-04-22 | $8.66B derived: sum of 2 quarters · filed 2026-02-06 | $13.31B derived: sum of 3 quarters · filed 2026-02-06 | $17.64B derived: sum of 4 quarters · filed 2026-02-06 |
| 2023-12-31 | $4.84B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $9.48B derived: sum of 2 quarters · filed 2026-02-06 | $13.81B derived: sum of 3 quarters · filed 2026-02-06 | $17.29B 10-K · filed 2026-02-06 |
| 2023-09-30 | $4.65B 10-Q · filed 2024-10-17 | $8.97B derived: sum of 2 quarters · filed 2024-10-17 | $12.46B 10-Q · filed 2024-10-17 | $16.10B derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $4.33B 10-Q · filed 2024-07-17 | $7.81B 10-Q · filed 2024-07-17 | $11.45B derived: sum of 3 quarters · filed 2025-02-20 | $14.89B derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $3.48B 10-Q · filed 2024-04-18 | $7.13B derived: sum of 2 quarters · filed 2025-02-20 | $10.56B derived: sum of 3 quarters · filed 2025-02-20 | $13.63B derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $3.65B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $7.08B derived: sum of 2 quarters · filed 2025-02-20 | $10.15B derived: sum of 3 quarters · filed 2025-02-20 | $13.04B 10-K · filed 2025-02-20 |
| 2022-09-30 | $3.44B 10-Q · filed 2023-10-18 | $6.51B derived: sum of 2 quarters · filed 2023-10-18 | $9.39B 10-Q · filed 2023-10-18 | $12.46B derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $3.07B 10-Q/A · filed 2023-09-29 | $5.95B 10-Q/A · filed 2023-09-29 | $9.02B derived: sum of 3 quarters · filed 2024-02-21 | $11.92B derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $2.88B 10-Q · filed 2023-04-19 | $5.95B derived: sum of 2 quarters · filed 2024-02-21 | $8.85B derived: sum of 3 quarters · filed 2024-02-21 | $11.46B derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $3.07B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $5.97B derived: sum of 2 quarters · filed 2024-02-21 | $8.58B derived: sum of 3 quarters · filed 2024-02-21 | $10.89B 10-K · filed 2024-02-21 |
| 2021-09-30 | $2.90B 10-Q · filed 2022-10-19 | $5.51B derived: sum of 2 quarters · filed 2022-10-19 | $7.83B 10-Q · filed 2022-10-19 | $10.35B derived: sum of 4 quarters · filed 2023-10-18 |
| 2021-06-30 | $2.61B 10-Q · filed 2022-07-20 | $4.93B 10-Q · filed 2022-07-20 | $7.45B derived: sum of 3 quarters · filed 2023-10-18 | $9.67B derived: sum of 4 quarters · filed 2023-10-18 |
| 2021-03-31 | $2.31B 10-Q · filed 2022-04-20 | $4.83B derived: sum of 2 quarters · filed 2023-10-18 | $7.06B derived: sum of 3 quarters · filed 2023-10-18 | $9.28B derived: sum of 4 quarters · filed 2023-10-18 |
| 2020-12-31 | $2.52B derived: 10-Q 12 month − 10-Q 9 month · filed 2023-10-18 | $4.74B derived: sum of 2 quarters · filed 2023-10-18 | $6.97B derived: sum of 3 quarters · filed 2023-10-18 | $8.95B 10-Q · filed 2023-10-18 |
| 2020-09-30 | $2.22B 10-Q · filed 2021-10-20 | $4.45B derived: sum of 2 quarters · filed 2021-10-20 | $6.43B 10-Q · filed 2021-10-20 | $7.58B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $2.23B 10-Q · filed 2021-07-21 | $4.21B 10-Q · filed 2021-07-21 | $5.36B derived: sum of 3 quarters · filed 2022-02-16 | $6.10B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $1.98B 10-Q · filed 2021-04-21 | $3.13B derived: sum of 2 quarters · filed 2022-02-16 | $3.88B derived: sum of 3 quarters · filed 2022-02-16 | $3.98B derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $1.15B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $1.89B derived: sum of 2 quarters · filed 2022-02-16 | $1.99B derived: sum of 3 quarters · filed 2022-02-16 | $1.99B 10-K · filed 2022-02-16 |
| 2019-09-30 | $745.00M 10-Q · filed 2020-10-28 | $843.00M derived: sum of 2 quarters · filed 2020-10-28 | $843.00M 10-Q · filed 2020-10-28 | $843.00M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-06-30 | $98.00M 10-Q · filed 2020-07-29 | $98.00M 10-Q · filed 2020-07-29 | $98.00M derived: sum of 3 quarters · filed 2021-02-18 | $98.00M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-03-31 | $0.00 10-Q · filed 2020-04-29 | $0.00 derived: sum of 2 quarters · filed 2021-02-18 | $0.00 derived: sum of 3 quarters · filed 2021-02-18 | $0.00 derived: sum of 4 quarters · filed 2021-02-18 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $0.00 derived: sum of 2 quarters · filed 2021-02-18 | $0.00 derived: sum of 3 quarters · filed 2021-02-18 | $0.00 10-K · filed 2021-02-18 |
| 2018-09-30 | $0.00 10-Q · filed 2019-10-23 | $0.00 derived: sum of 2 quarters · filed 2019-10-23 | $0.00 10-Q · filed 2019-10-23 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-07-24 | $0.00 10-Q · filed 2019-07-24 | ||
| 2017-12-31 | $0.00 10-K · filed 2020-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |